Thromb Haemost 1969; 22(02): 216-222
DOI: 10.1055/s-0038-1651436
Originalarbeiten-Original Articles-Travaux Originaux
Schattauer GmbH

Abnormal Fibrin Stabilization in Renal Failure

M. S Losowsky M. D., F. R. C. P. Reader in Medicine
1   Department of Medicine, The University of Leeds, The General Infirmary, Leeds LSI 3EX.
,
W. D Walls M. B., Ch. B., M. R. C. P. Senior Registrar in Medicine
1   Department of Medicine, The University of Leeds, The General Infirmary, Leeds LSI 3EX.
› Author Affiliations
Further Information

Publication History

Publication Date:
10 June 2018 (online)

Summary

Plasma F.S.F. activity was measured by a quantitative technique in 41 patients with renal failure. It was subnormal in 35, being undemonstrable in 32.

There was no significant difference in activity between patients with acute and patients with chronic renal failure, and co-existing jaundice had no significant effect on plasma F. S. F. activity.

Plasma fibrinogen concentrations were frequently increased. Patients with the highest levels of plasma fibrinogen tended to retain demonstrable F.S.F. activity.

Plasma F.S.F. activity was not related to the height of the blood urea.

Haemodialysis and peritoneal dialysis had no significant effect on plasma F.S.F. activity.

Plasma F.S.F. activity returned to normal following recovery of acute renal failure.

Diminished plasma F.S.F. activity did not appear to be responsible for abnormal haemorrhage although it may act as a contributory factor.

It is suggested that impaired fibrin stabilization might be responsible for abnormal wound healing in uraemia.

 
  • References

  • 1 Riesman D. Hemorrhages in the course of Bright’s disease, with especial reference to the occurrence of a hemorrhagic diathesis of nephritic origin. Amer. J. med. Sci. 134: 709 1097;
  • 2 Baserga A, Ballerini G. Acquired platelet defects. Proc. 9th Congr. europ. Soc. Haemat., Lisbon 1963. P. 1213 (1963).
  • 3 Rath C. E, Mailliard J. A, Schreiner G. E. Bleeding tendency in uremia. New. Engl. J. Med. 257: 808 1957;
  • 4 Donner L, Neuwirtová R. The hemostatic defect of acute and chronic uremia. Thrombos. Diathes. haemorrh. (Stuttg.) 5: 319 1961;
  • 5 Teschan P. E, Post R. S, Smith L. H, Abernathy R. S, Davis J. H, Gray D. M, Howard J. M, Johnson K. E, Klopp E, Mundy R. L, O’Meara M. P, Rush B. F. Post-traumatic renal insufficiency in military casualties. I. Clinical Characteristics. Amer. J. Med. 18: 172 1955;
  • 6 Bluemle L. W, Webster G. D, Elkinton J. R. Acute tubular necrosis. Analysis of 100 cases with respect to mortality, complications and treatment with and without dialysis. Arch, intern. Med. 104: 180 1959;
  • 7 Kendall A. G, Lowenstein L, Morgen R. O. The hemorrhagic diathesis in renal disease with special reference to acute uremia. Canad. med. Ass. J. 85: 405 1961;
  • 8 Meroney W. H, Herndon R. F. The management of acute renal insufficiency J. Amer. med. Ass. 155: 877 1954;
  • 9 Kuhlback B. The bleeding tendency in chronic renal failure. Acta med. scand. 157: 173 1957;
  • 10 Cheney K, Bonnin J. A. Haemorrhage, platelet dysfunction and other coagulation defects in uraemia. Brit. J. Haemat. 8: 215 1962;
  • 11 Altschuler G, Marcus A. J, Oilman H. L. Platelets and platelet phosphatides in uremia. Blood 16: 1439 1960;
  • 12 Castaldi P. A, Bozenberg M. C, Stewart J. H. The bleeding disorder of uraemia. A qualitative platelet defect. Lancet II: 66 1966;
  • 13 Lewis J. H, Zucker M. B, Ferguson J. H. Bleeding tendency in uremia. Blood 11: 1073 1956;
  • 14 Willoughby M. L. N, Crouch S. J. An investigation of the haemorrhagic tendency in renal failure. Brit. J. Haemat. 7: 315 1961;
  • 15 von Kaulla K. N, von Kaulla E, Wasantapruck S, Marchioro T. L, Starzl T. E. Blood coagulation in uremic patients before and after hemodialysis and transplantation of the kidney. Arch. Surg. 92: 184 1966;
  • 16 Larrain C, Adelson E. The hemostatic defect of uremia. I. Clinical investigation of three patients with acute posttraumatic renal insufficiency. Blood 11: 1059 1956;
  • 17 Walls W. D. M, Losowsky S. Congenital deficiency of fibrinstabilizing factor. Coagulation 1: 111 1968;
  • 18 Nussbaum M, Morse B. S. Plasma fibrin stabilizing factor activity in various diseases. Blood 23: 669 1964;
  • 19 Ottoviani P, Mandelli F, Fontana L, Morelli R. Il fattore stabilizzante fìbrinico di Laki e Lorand nelle sarcomatosi istiocitarie a tendenza sistemica. Progresso med., Napoli 21: 10 1965;
  • 20 Ottaviani P, Mandelli F, Fontana L, Morelli R. Compartamento del fattore stabilizzante fìbrinico nelle epatopatie. Progresso med., Napoli 21: 115 1965;
  • 21 Maliarovskii V. N. The activity of fibrinase in cirrhosis of the liver and in chronic hepatitis. Terap. Arkh. 39: 61 1967;
  • 22 Walls W. D, Losowsky M. S. Plasma fibrin stabilizing factor activity (F. S. F.) in normal subjects and patients with chronic liver disease. Thrombos. Diathes. haemorrh. (Stuttg.) 21: 134 1969;
  • 23 Walls W. D, Losowsky M. S. (In preparation).
  • 24 Horowitz H. I, Cohen B. D, Martinez P, Papayoanou M. F. Defective ADP-induced platelet factor 3 activation in uremia. Blood 30: 331 1967;
  • 25 Stewart J. H, Castaldi P. A. Uraemic bleeding: A reversible platelet defect corrected by dialysis. Quart. J. Med. (N. S.) 36: 409 1967;
  • 26 Nayman J. Effect of renal failure on wound healing in dogs. Response to hemodialysis following uremia induced by uranium nitrate. Ann. Surg. 164: 227 1966;
  • 27 Mott T. J, Ellis H. A method of producing experimental uraemia in the rabbit with some observations on the influence of uraemia on peritoneal healing. Brit. J. Urol. 39: 341 1967;